Molecular neurobiology of drug addiction

Annual Review of Medicine

Volumn 55, Issue , 2004, Pages 113-132

  Chao, Jennifer ^a   Nestler, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

FosB; CREB; Mesolimbic dopamine; Nucleus accumbens; Reward

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; NEUROTROPHIC FACTOR; OPIATE; PROTEIN FOS; TRANSCRIPTION FACTOR;

BRAIN NERVE CELL; CELL STRUCTURE; CELL TYPE; DRUG DEPENDENCE; DRUG TOLERANCE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; GENE EXPRESSION; HUMANS; NEURONAL PLASTICITY; SUBSTANCE-RELATED DISORDERS; TRANSCRIPTION FACTORS;

EID: 1542358989     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.55.091902.103730     Document Type: Review

References (114)

1. Robinson TE, Berridge KC. 2003. Addiction. Annu. Rev. Psychol. 54:25-53
2. Solomon RL. 1980. The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain. Am. Psychol. 35:691-712
3. Koob GF, Le Moal M. 2001. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24: 97-129
4. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18:247-91
5. Robinson TE, Berridge KC. 2000. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95:S91-117
6. Berke JD, Hyman SE. 2000. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25:515-32
7. Di Chiara G. 1999. Drug addiction as dopamine-dependent associative learning disorder. Eur. J. Pharmacol. 375:13-30
8. Everitt BJ, Dickinson A, Robbins TW. 2001. The neuropsychological basis of addictive behaviour. Brain Res. Brain Res. Rev. 36:129-38
9. Lonze BE, Ginty DD. 2002. Function and regulation of CREB family transcription factors in the nervous system. Neuron 35:605-23
10. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2:599-609
11. Chan HM, La Thangue NB. 2001. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114:2363-73
12. Guitart X, Thompson MA, Mirante CK, et al. 1992. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58:1168-71
13. Sharma SK, Klee WA, Nirenberg M. 1975. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72:3092-96
14. Nestler EJ, Aghajanian GK. 1997. Molecular and cellular basis of addiction. Science 278:58-63
15. Nestler EJ. 2001. Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci. 2:119-28
16. Foote SL, Bloom FE, Aston-Jones G. 1983. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63:844-914
17. Aston-Jones G, Rajkowski J, Cohen J. 1999. Role of locus coeruleus in attention and behavioral flexibility. Biol. Psychiatry 46:1309-20
18. Lane-Ladd SB, Pineda J, Boundy VA, et al. 1997. CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17:7890-901
19. Widnell KL, Russell DS, Nestler EJ. 1994. Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc. Natl. Acad. Sci. USA 91:10947-51
20. Chao JR, Ni YG, Bolanos CA, et al. 2002. Characterization of the mouse adenylyl cyclase type VIII gene promoter: regulation by cAMP and CREB. Eur. J. Neurosci. 16:1284-94
21. Maldonado R, Blendy JA, Tzavara E, et al. 1996. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273:657-59
22. Walters CL, Blendy JA. 2001. Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J. Neurosci. 21:9438-44
23. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, et al. 1991. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:100-10
24. Unterwald EM, Cox BM, Kreek MJ, et al. 1993. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse 15:33-38
25. Barrot M, Olivier JD, Perrotti LI, et al. 2002. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. USA 99:11435-40
26. Shaw-Lutchman TZ, Barrot M, Wallace T, et al. 2002. Regional and cellular mapping of cAMP response element-mediated transcription during naltrexone-precipitated morphine withdrawal. J. Neurosci. 22:3663-72
27. Shaw-Lutchman TZ, Impey S, Storm D, Nestler EJ. 2003. Regulation of CRE-mediated transcription in mouse brain by amphetamine. Synapse 48:10-17
28. Self DW, Genova LM, Hope BT, et al. 1998. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18:1848-59
29. Carlezon WA Jr, Thome J, Olson VG, et al. 1998. Regulation of cocaine reward by CREB. Science 282:2272-75
30. Sakai N, Thome J, Newton SS, et al. 2002. Inducible and brain region-specific CREB transgenic mice. Mol. Pharmacol. 61:1453-64
31. Deleted in proof
32. Hyman SE, Malenka RC, Spangler R, et al. 2001. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2:695-703
33. Pliakas AM, Carlson RR, Neve RL, et al. 2001. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 21:7397-403
34. Newton SS, Thome J, Wallace T, et al. 2002. Inhibition of CREB or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 22:10883-90
35. Daunais JB, McGinty JF. 1995. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Brain Res. Mol. Brain Res. 29:201-10
36. Spangler R, Ho A, Zhou Y, et al. 1996. Regulation of kappa opioid receptor mRNA in the rat brain by "binge" pattern cocaine administration and correlation with preprodynorphin mRNA. Brain Res. Mol. Brain Res. 38:71-76
37. Cole RL, Konradi C, Douglass J, Hyman SE. 1995. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14:813-23
38. Shippenberg TS, Rea W. 1997. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol. Biochem. Behav. 57:449-55
39. Spanagel R, Herz A, Shippenberg TS, et al. 1992. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl. Acad. Sci. USA 89:2046-50
40. Mumberg D, Lucibello FC, Schuermann M, Muller R. 1991. Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev. 5:1212-23
41. Hope BT, Nye HE, Kelz MB, et al. 1994. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13:1235-44
42. Moratalla R, Elibol B, Vallejo M, et al. 1996. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17:147-56
43. Young ST, Porrino LJ, Iadarola MJ. 1991. Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA 88:1291-95
44. Graybiel AM, Moratalla R, Robertson HA. 1990. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA 87:6912-16
45. Hope B, Kosofsky B, Hyman SE, Nestler EJ. 1992. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. USA 89:5764-68
46. Chen J, Kelz MB, Hope BT, et al. 1997. Chronic Fos-related antigens: stable variants of ΔFosB induced in brain by chronic treatments. J. Neurosci. 17:4933-41
47. Andersson M, Westin JE, Cenci MA, et al. 2003. Time course of striatal ΔFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment. Eur. J. Neurosci. 17:661-66
48. Nye HE, Hope BT, Kelz MB, et al. 1995. Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 275:1671-80
49. Nye HE, Nestler EJ. 1996. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. Mol. Pharmacol. 49:636-45
50. Pich EM, Pagliusi SR, Tessari M, et al. 1997. Common neural substrates for the addictive properties of nicotine and cocaine. Science 275:83-86
51. Ryabinin AE, Wang YM. 1998. Repeated alcohol administration differentially affects c-Fos and FosB protein immunoreactivity in DBA/2J mice. Alcohol Clin. Exp. Res. 22:1646-54
52. Kelz MB, Nestler EJ. 2000. ΔFosB: a molecular switch underlying long-term neural plasticity. Curr. Opin. Neurol. 13: 715-20
53. Atkins JB, Chlan-Fourney J, Nye HE, et al. 1999. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse 33:118-28
54. Hiroi N, Graybiel AM. 1996. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. Comp. Neurol. 374:70-83
55. Werme M, Messer C, Olson L, et al. 2002. ΔFosB regulates wheel running. J. Neurosci. 22:8133-38
56. Chen J, Kelz MB, Zeng G, et al. 1998. Transgenic animals with inducible, targeted gene expression in brain. Mol. Pharmacol. 54:495-503
57. Kelz MB, Chen J, Carlezon WA Jr, et al. 1999. Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine. Nature 401:272-76
58. Colby CR, Whisler K, Steffen C, et al. 2003. Striatal cell type-specific overexpression of ΔFosB enhances incentive for cocaine. J. Neurosci. 23:2488-93
59. Nestler EJ, Barrot M, Self DW. 2001. ΔFosB: a sustained molecular switch for addiction. Proc. Natl. Acad. Sci. USA 98:11042-46
60. Peakman MC, Colby C, Perrotti LI, et al. 2003. Inducible, brain region-specific expression of a dominant negative mutant of c-Jun in transgenic mice decreases sensitivity to cocaine. Brain Res. 970:73-86
61. Hiroi N, Brown JR, Haile CN, et al. 1997. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc. Natl. Acad. Sci. USA 94:10397-402
62. Shaw TZ, Gilden L, Kelz MB, et al. 2000. Regulation of neuropeptide expression by ΔFosB in striatum. Society for Neuroscience Abstracts 26:525
63. Chen J, Zhang Y, Kelz MB, et al. 2000. Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: role of ΔFosB. J. Neurosci. 20:8965-71
64. Ang E, Chen J, Zagouras P, et al. 2001. Induction of nuclear factor-κB in nucleus accumbens by chronic cocaine administration. J. Neurochem. 79:221-24
65. Bibb JA, Chen J, Taylor JR, et al. 2001. Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410:376-80
66. Cha XY, Pierce RC, Kalivas PW, Mackler SA. 1997. NAC-1, a rat brain mRNA, is increased in the nucleus accumbens three weeks after chronic cocaine self-administration. J. Neurosci. 17:6864-71
67. Kalivas PW, Duffy P, Mackler SA. 1999. Interrupted expression of NAC-1 augments the behavioral responses to cocaine. Synapse 33:153-59
68. Mackler SA, Korutla L, Cha XY, et al. 2000. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J. Neurosci. 20:6210-17
69. Bannon MJ, Pruetz B, Manning-Bog AB, et al. 2002. Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proc. Natl. Acad. Sci. USA 99:6382-85
70. Toda S, McGinty JF, Kalivas PW. 2002. Repeated cocaine administration alters the expression of genes in corticolimbic circuitry after a 3-week withdrawal: a DNA microarray study. J. Neurochem. 82:1290-99
71. Sklair-Tavron L, Shi WX, Lane SB, et al. 1996. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl. Acad. Sci. USA 93:11202-7
72. Beitner-Johnson D, Nestler EJ. 1993. Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system. Neuroreport 5:57-60
73. Beitner-Johnson D, Guitart X, Nestler EJ. 1992. Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J. Neurosci. 12:2165-76
74. Robinson TE, Kolb B. 1999. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11:1598-604
75. Robinson TE, Kolb B. 1997. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17:8491-97
76. Robinson TE, Gorny G, Mitton E, Kolb B. 2001. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 39:257-66
77. Self DW, McClenahan AW, Beitner-Johnson D, et al. 1995. Biochemical adaptations in the mesolimbic dopamine system in response to heroin self-administration. Synapse 21:312-18
78. Barde YA. 1989. Trophic factors and neuronal survival. Neuron 2:1525-34
79. Lu B, Figurov A. 1997. Role of neurotrophins in synapse development and plasticity. Rev. Neurosci. 8:1-12
80. Korsching S, Turgeon SM, Pollack AE, Fink JS. 1993. The neurotrophic factor concept: a reexamination. J. Neurosci. 13:2739-48
81. Thoenen H. 1995. Neurotrophins and neuronal plasticity. Science 270:593-98
82. Pierce RC, Bari AA. 2001. The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev. Neurosci. 12:95-110
83. Nestler EJ, Berhow MT, Brodkin ES. 1996. Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol. Psychiatry 1:190-99
84. Horger BA, Iyasere CA, Berhow MT, et al. 1999. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19:4110-22
85. Martin-Iverson MT, Todd KG, Altar CA. 1994. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine. J. Neurosci. 14:1262-70
86. Pierce RC, Pierce-Bancroft AF, Prasad BM. 1999. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/mitogen-activated protein kinase signal transduction cascade. J. Neurosci. 19:8685-95
87. Grimm JW, Lu L, Hayashi T, et al. 2003. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving. J. Neurosci. 23:742-47
88. Guillin O, Diaz J, Carroll P, et al. 2001. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411:86-89
89. Pilla M, Perachon S, Sautel F, et al. 1999. Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400:371-75
90. Vorel SR, Ashby CR Jr, Paul M, et al. 2002. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J. Neurosci. 22:9595-603
91. Akbarian S, Rios M, Liu RJ, et al. 2002. Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons. J. Neurosci. 22:4153-62
92. Messer CJ, Eisch AJ, Carlezon WA Jr, et al. 2000. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26:247-57
93. Akbarian S, Bates B, Liu RJ, et al. 2001. Neurotrophin-3 modulates noradrenergic neuron function and opiate withdrawal. Mol. Psychiatry 6:593-604
94. Berhow MT, Hiroi N, Kobierski LA, et al. 1996. Influence of cocaine on the JAK-STAT pathway in the mesolimbic dopamine system. J. Neurosci. 16:8019-26
95. Berhow MT, Hiroi N, Nestler EJ. 1996. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16:4707-15
96. Berhow MT, Russell DS, Terwilliger RZ, et al. 1995. Influence of neurotrophic factors on morphine-and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68:969-79
97. Bolanos CA, Perrotti LI, Edwards S, et al. 2003. Phospholipase Cγ in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors. J. Neurosci. 23:7569-76
98. Wolf DH, Numan S, Nestler EJ, Russell DS. 1999. Regulation of phospholipase Cγ in the mesolimbic dopamine system by chronic morphine administration. J. Neurochem. 73:1520-28
99. Patapoutian A, Reichardt LF, Berhow MT, Brodkin ES. 2001. Trk receptors: mediators of neurotrophin action. Curr. Opin. Neurobiol. 11:272-80
100. Dhavan R, Tsai LH, Berhow MT, Brodkin ES. 2001. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2:749-59
101. Norrholm SD, Bibb JA, Nestler EJ, et al. 2003. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 116:19-22
102. Harada T, Morooka T, Ogawa S, Nishida E. 2001. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 3:453-59
103. Tokuoka H, Saito T, Yorifuji H, et al. 2000. Brain-derived neurotrophic factor-induced phosphorylation of neurofilament-H subunit in primary cultures of embryo rat cortical neurons. J. Cell Sci. 113:1059-68
104. White NM. 1996. Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91:921-49; discussion 51-65
105. Koob GF, Le Moal M. 2001. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129
106. Vorel SR, Liu X, Hayes RJ, et al. 2001. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 292:1175-78
107. Eisch AJ, Barrot M, Schad CA, et al. 2000. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl. Acad. Sci. USA 97:7579-84
108. Crews FT, Miller MW, Ma W, et al. 2003. Neural stem cells and alcohol. Alcohol Clin. Exp. Res. 27:324-35
109. Abrous DN, Adriani W, Montaron MF, et al. 2002. Nicotine self-administration impairs hippocampal plasticity. J. Neurosci. 22:3656-62
110. Eisch AJ. 2002. Adult neurogenesis: implications for psychiatry. Prog. Brain Res. 138:315-42
111. Rueda D, Navarro B, Martinez-Serrano A, et al. 2002. The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. J. Biol. Chem. 277:46645-50
112. Gould E, Gross CG. 2002. Neurogenesis in adult mammals: some progress and problems. J. Neurosci. 22:619-23
113. Shors TJ, Townsend DA, Zhao M, et al. 2002. Neurogenesis may relate to some but not all types of hippocampal-dependent learning. Hippocampus 12: 578-84
114. Nestler EJ. 2001. Molecular neurobiology of addiction. Am. J. Addiction 201:201-217